Insider Transactions in Q4 2024 at Axonics, Inc. (AXNX)
Insider Transaction List (Q4 2024)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Nov 15
2024
|
Esteban Lopez |
SELL
Sale (or disposition) back to the issuer
|
Direct |
6,600
-100.0%
|
$468,600
$71.0 P/Share
|
Nov 15
2024
|
Robert Mc Namara |
SELL
Sale (or disposition) back to the issuer
|
Direct |
14,861
-100.0%
|
$1,055,131
$71.0 P/Share
|
Nov 15
2024
|
Karen Noblett Chief Medical Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
34,428
-100.0%
|
$2,444,388
$71.0 P/Share
|
Nov 15
2024
|
Rinda Sama Chief Operating Officer |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
608
-100.0%
|
$43,168
$71.0 P/Share
|
Nov 15
2024
|
Rinda Sama Chief Operating Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
83,854
-100.0%
|
$5,953,634
$71.0 P/Share
|
Nov 15
2024
|
Nancy Lynn Md Snyderman |
SELL
Sale (or disposition) back to the issuer
|
Direct |
14,944
-100.0%
|
$1,061,024
$71.0 P/Share
|
Nov 15
2024
|
John Woock EVP, Chief Mktg/Strtgy Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
77,403
-100.0%
|
$5,495,613
$71.0 P/Share
|
Nov 15
2024
|
Jane E Kiernan |
SELL
Sale (or disposition) back to the issuer
|
Direct |
19,861
-100.0%
|
$1,410,131
$71.0 P/Share
|
Nov 15
2024
|
Michael H Carrel |
SELL
Sale (or disposition) back to the issuer
|
Direct |
17,861
-100.0%
|
$1,268,131
$71.0 P/Share
|
Nov 15
2024
|
Raymond W Cohen Chief Executive Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
292,731
-100.0%
|
$20,783,901
$71.0 P/Share
|
Nov 15
2024
|
David M Demski |
SELL
Sale (or disposition) back to the issuer
|
Direct |
9,542
-100.0%
|
$677,482
$71.0 P/Share
|
Nov 15
2024
|
Alfred J Ford Jr Chief Commercial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
43,450
-100.0%
|
$3,084,950
$71.0 P/Share
|
Nov 15
2024
|
Kari Leigh Keese Chief Financial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
40,362
-100.0%
|
$2,865,702
$71.0 P/Share
|
Nov 07
2024
|
Nancy Lynn Md Snyderman |
SELL
Bona fide gift
|
Direct |
5,000
-25.07%
|
-
|
Oct 02
2024
|
Kari Leigh Keese Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,961
-3.44%
|
$204,309
$69.41 P/Share
|